Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Asia-2020-Virtual-1000x250

The abstract submission system is now closed

Outcome notifications

Outcome notifications are expected to be made available to first authors by mid-September 2020.

Abstract submission deadlines

Deadline

Date and time

Abstracts

22 July 2020, 12:00 SGT (local Singapore Time) / 12:00 CEST (Central European Summer Time)

Late-breaking abstracts

Final submission deadline* 07 October 2020, 18:00 SGT (local Singapore time) / 12:00 CEST (Central European Summer Time)

Late-breaking abstracts

*A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline 22 July 2020.

The deadline for the submission of finalised late-breaking abstracts is 18:00 hrs SGT (local Singapore Time) / 12:00 CEST (Central European Summer Time) on 07 October 2020.

Abstract submission categories

  • Breast cancer, early stage
  • Breast cancer, locally advanced
  • Breast cancer, metastatic
  • Developmental therapeutics
  • Gastrointestinal tumours, colorectal
  • Gastrointestinal tumours, non-colorectal
  • Genitourinary tumours, prostate
  • Genitourinary tumours, non-prostate
  • Gynaecological cancers
  • Haematological malignancies
  • Head and neck cancer, excluding thyroid
  • Palliative care
  • Precision medicine
  • SARS-CoV-2 and cancer​
  • Supportive care
  • Thoracic tumours, early stage
  • Thoracic tumours, locally advanced
  • Thoracic tumours, metastatic
  • Miscellaneous

The ESMO Asia 2020 Scientific Committee selected abstracts for presentation during the Congress based on the following possibilities:

  • Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives. 
  • Mini Oral – Short presentation by the authors with comment and interactive audience discussion led by an invited expert. 
  • Poster – Display sessions for review, discussion and questions. Posters will be displayed for the duration of the Congress and the presenting authors must be available for Q&A for one hour to represent their work.

All accepted abstracts are published in the ESMO Asia 2020 Abstract Book, a supplement to Annals of Oncology, except YO Patient case study Posters.

Publication schedule for accepted abstracts

  1. Abstracts accepted for presentation at ESMO Asia 2020 as Proffered Paper (oral Presentation), Mini Oral and Poster will be published online on the ESMO website at 00:05 hrs SGT (local Singapore Time) on Wednesday, 18 November 2020.
  2. Late-breaking abstracts will be made public at 00:05 hrs SGT (local Singapore Time) on the day of presentation in the official ESMO Asia 2020 Congress programme.
  3. ESMO Press Programme and related abstract publication schedule, will be available 10 days before the Congress.

    i.e.,:

Abstracts

Date and time

Abstracts accepted as:

  • Proffered Paper (suffix 'O')
  • Mini Oral (suffix 'O')
  • Poster (suffix 'P')

Wednesday, 18 November 2020
00:05 hrs SGT (local Singapore Time)

Tuesday, 17 November 2020
17:05 hrs CET (Central European Time) 

Late-breaking abstracts (prefix 'LBA')

00:05 hrs SGT (local Singapore Time) on the day of presentation during the official ESMO Asia 2020 Congress programme.

Abstracts and LBAs selected for the official ESMO Press Programme (additional suffix 'PR')

ESMO Press Programme and related abstract publication schedule, will be available 10 days before the Congress

Travel grant

A restricted number of Travel grant to ESMO Asia 2020 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the ESMO Asia 2020 Scientific Committee on a competitive basis from among the accepted abstracts.

The application is now closed.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings